baber/WOPTO huggingface dataset:
Patent CA-2372747-A1 (CA)
Title: Pressure vessel manufacture method
Inventor: LEBRETON EDWARD T
IPC: B29C43/52
Filed: 2002-02-21
Abstract: A method of molding a hollow, reinforced molded plastic article. A preform is provided in the shape of the article to be molded. The preform comprises randomly commingled, short lengths of thermoplastic and reinforcing fibers loosely bonded together. A core is provided within the preform and may either be a flexible inflatable core which may be removed later or a thermoplastic liner. The preform is placed in a mold and heated to fuse the thermoplastic while a pressurized liquid coolant is circulated within the core.
Patent CA-2373347-A1 (CA)
Inventor: WANG BENJAMIN N
IPC: B01L3/00
Filed: 2000-05-11
Abstract: Methods and systems for particle focusing to increase assay throughput in microscale systems are provided. The invention includes methods for providing substantially uniform flow velocity to flowing particles in microfluidic devices. Methods of sorting members of particle populations, such as cells and various subcellular components are also provided. Integrated systems in which particles are focused and/or sorted are additionally included.
Patent CA-2373469-A1 (CA)
Inventor: CHEN JIANGNAN
IPC: H04W36/36
Filed: 2001-03-12
Abstract: A method and apparatus for long code generation in synchronous, multi-chip rate systems (200), wherein a first code sequence having a first bit rate (205), and a second code sequence having the first bit rate (215, 225), the second code sequence being a time delay (210, 212) of the first code sequence, are multiplexed together (208), producing a desired long code (216).
Patent CA-2376582-A1 (CA)
Title: Gas turbine plant with high detection sensitivity of extraordinary state
Inventor: KOMIYAMA HIROYA
IPC: F02C9/28
Filed: 2002-03-13
Abstract: A gas turbine plant includes a combustion section (3), a turbine section (2), an exhaust section (12), a temperature detecting unit (13), and a monitoring unit (15). The combustion section combusts fuel using air to generate combustion gas. The turbine section is driven with the combustion gas from the combustion section. The exhaust section is connected to the turbine section to exhaust the combustion gas from the turbine section. The temperature detecting unit is provided in the exhaust section to measure a temperature of the combustion gas. The monitoring unit generates a warning signal based on a tolerable level and data corresponding to a temporal change of the temperature measured by the temperature detecting unit to indicate an extraordinary state of the gas turbine plant.
Patent CA-2379976-A1 (CA)
Title: Method and apparatus for maintaining context while executing translated instructions
Inventor: CMELIK ROBERT
IPC: G06F9/45
Filed: 2000-09-06
Abstract: A method (fig. 1) of maintaining translation context for instructions translated from instructions designed for a target microprocessor to run on a host microprocessor including storing translation context related to each translated host instruction, indicating a translation context for host instructions presently being executed by the host processor, comparing (fig. 2) translation context stored for a next host instruction with the translation context for a host instruction presently being executed, executing the next host instruction if the translation context of the next host instruction and the presently executing host instruction compare, and searching (fig. 2) for an instruction with translation context which compares to the translation context of the host instruction presently executing if the translation context of the next host instruction and the presently executing host instruction do not compare.
Patent CA-2381237-A1 (CA)
Title: Switch actuator
Inventor: HILLEGERS DICK
IPC: H01H5/06
Filed: 2000-08-07
Abstract: The present invention consists in a switch actuator to move an air brake switch (124) such as those commonly found in power transmission lines, between an open and closed position wherein the actuator (4) includes a first rotatable member in me-chanical connection with and to move said switch (124) between said open and closed position by the rotation of said rotatable member, a second rotatable member in mechanical connection with an actuator such as a linear drive motor (8), a connection mem-ber rotatable about the same pivot axis as the first and second members, the connection member being biased for rotation about the pivot axis in a toggle manner and providing a mechanical connection means to locate (a) against a fixed point of, and be displaced by, said second rotatable means at least during the rotation of the connection member by the second rotation means towards the point of toggle of the connection means, and (b) against a fixed point of and to thereby displace, the first rotatable member at least during rotation of said connection member passed said point of toggle.
Patent CA-2381609-A1 (CA)
Inventor: DUSHMAN LAWRENCE M
IPC: B65D47/36
Filed: 2002-04-12
Abstract: A hygienic bottle cap for connection to a fluid container includes a skirt and a crown portion having a cylindrical wall with an upper portion and a lower portion and forms a central well. A flapper forming a portion of the bottom surface of the center well is attached to the cylindrical wall. A score line is formed partially around the perimeter of the flapper between the flapper and the cylindrical wall, and the portion of the perimeter that is not scored remains intact upon insertion of a probe. The flapper may be separated from the cylindrical wall by the probe, and may return to its initial sealed position after the probe is retracted. In one embodiment, a protrusion is supported on an underside of the flapper in order to facilitate separation of the flapper from the cylindrical wall along the score line.
Patent CA-2381849-A1 (CA)
Title: Antimycotic drug
Inventor: STEIGER ROLF FRANKLIN
IPC: C07C217/84
Filed: 2000-08-29
Abstract: Described is the excellent and safe antimycotic action of the compound of formula (I) wherein Y is a completely or partially halogenated C1-C6alkyl or a completely or partially halogenated and with an oxygen atom interrupted C1-C6alkyl or a completely or partially halogenated C2-C6alkenyl; R1, R2, R3 and R4 are independently of each other hydrogen, halogen, C1-C6alkyl, C1-C6haloalkyl, C1-C6haloalkoxy, X1 is hydrogen or C1-C6alkyl, X2 is hydrogen or C1-C6alkyl. Further described are antimycotic drugs comprising as active ingredient at least one of said compounds, and to the use of said compounds and antimycotic compositions for the treatment of mycotic infections in humans or animals.
Patent CA-2382865-A1 (CA)
Inventor: LAURENCE TIMOTHY
IPC: G09F3/02
Filed: 2000-08-24
Abstract: A label (10) with booklet (32) comprises a liner (12) and a label (10) havin g an upper and lower surface located on the liner (12). The label (10) is secured to the liner (12) by an adhesive layer (18) on its lower surface suc h that the label (10) can be peeled off the liner (12) with the adhesive remaining on the lower surface of the label (10). A booklet (32) further comprises a cover member (40) entirely covering the top page and extending beyond at least two opposing edges of the top page, the cover member (40) having an upper non-adhesive surface, and a lower surface having an adhesive  thereon by means of which the lower surface of the cover member (40) is permanently adhered to the upper surface of the top page. The booklet (32) i s completely removable from the label (10) by removing at least a portion of t he cover member (40).
Patent CA-2383131-A1 (CA)
Title: Formulation
Inventor: BROWN DANIEL BOYD
IPC: A61K9/00
Filed: 2000-09-18
Abstract: Granules contenant de la quétiapine et des sels pharmaceutiquement acceptables de ladite substance, ainsi que leur préparation et leur utilisation pour traiter des maladies du système nerveux central telles que les états psychotiques, dont la schizophrénie.
Patent CA-2383476-A1 (CA)
Inventor: HYLANDS DAVE
IPC: H04N1/52
Filed: 2000-08-30
Abstract: A raster image processing system (20) for producing the appropriate number and set of halftoned color separations for a select output device (24) is disclosed. The raster image processing system (20) includes a processing unit (30), an interpreter (32) and a color combiner (34). The interpreter (32) and color combiner (34) are application processes that are controlled by software running on the processing unit (30). The processing unit (30) identifies the number and set of colorants used to describe input image data and the number and set of halftoned color separations that a select output imaging device (24) is capable of rendering. The interpreter (32) converts the input data describing an image that is composed of "N" colorants into "N" halftoned color separations. The color combiner (34) thereafter converts the N halftoned color separations into "M" halftoned color separations that are ideally suited for the particular output device (24) chosen by a user of the system. The color combiner (34) performs this conversion by utilizing digital filtering and combining processes.
Patent CA-2386143-A1 (CA)
Title: Formulation liposomique de dimaleate de 6,9-bis-[(2-aminoethyl)-amino]benzo[g]isoquinoline-5,10-dione
Inventor: BUGATTI CARLO
IPC: A61K47/24
Filed: 2000-10-19
Abstract: L'invention concerne une formulation pharmaceutique liposomique de dimaléate de 6,9-bis-[(2-aminoéthyl)amino]benzo[g]isoquinoline-5,10-dione, son procédé de préparation, ainsi que son utilisation.
Patent CA-2388535-A1 (CA)
Inventor: BARBAS CARLOS F
IPC: A61K48/00
Filed: 2000-10-23
Abstract: Fusion proteins for use as ligand-dependent transcriptional are provided. The fusion proteins include a nucleotide binding domain operatively linked to a ligand-binding domain. They also can include a transcription regulating domain. The nucleotide binding domain is a zinc-finger peptide that binds to a targeted contiguous nucleotide sequence of from 3 to 18 nucleotides are provided. The fusion proteins are used for gene therapy. Also provided are polynucleotides encoding the fusion proteins, expression vectors, and transfected cells.
Patent CA-2390827-A1 (CA)
Title: Cable gland assemblies
Inventor: JACKSON CARL
IPC: H02G15/04
Filed: 2001-01-22
Abstract: A cable gland assembly (1) has parts (2, 4, 6) providing a mechanical and/or electrical connection between a cable C and a wall. A tag (200) for providing an electrical connection between the assembly (1) and/or wall and earth is clamped between (2, 4, 6) of the assembly (1) or a part (2, 4, 6) and the wall. The tag has an aperture (208) through which a part of the assembly is received and means (214) for opposing rotation of the tag about a part of the assembly during clamping.
Patent CA-2391098-A1 (CA)
Title: Recombinant .alpha.-l-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
Inventor: CHAN WIA-PAN
IPC: A61P19/00
Filed: 2000-11-09
Abstract: The present invention provides a recombinant human .alpha.-L-iduronidase and biologically active fragments and mu-tants thereof, large scale methods to produce and purify commercial grade recombinant human .alpha.-L-iduronidase enzyme as well as methods to treat certain genetic disorders including .alpha.-L-iduronidase deficiency and mucopolysaccharidosis I (MPS 1).
Patent CA-2393363-A1 (CA)
Title: Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1b (ptp-1b)
Inventor: WANG ZHAOYIN
IPC: A61P3/06
Filed: 2000-12-21
Abstract: The invention encompasses the novel class of compounds represented by formul a (I), which are inhibitors of the PTP-1B enzyme. The invention also encompass es pharmaceutical compositions and methods of treating or preventing PTP-1B mediated diseases, including diabetes, obesity, and diabetes-related disease s.
Patent CA-2393895-A1 (CA)
Title: Serological test for isav in fish
Inventor: KIBENGE MOLLY T
IPC: C12Q1/70
Filed: 2002-07-17
Abstract: There is disclosed immune assays and kits for detecting antibodies to infectious salmon anaemia virus (ISAV).      The method comprises contacting the ISAV or ISAV antigen with an antibody-containing sample from fish, and detecting specific binding between the antibody and the ISAV or ISAV antigen.
Patent CA-2395670-A1 (CA)
Inventor: STANTON KEVIN B
IPC: H04L12/56
Filed: 2000-11-21
Abstract: L'invention concerne un moteur de commutation de paquets de réseau (100). Ce moteur de commutation produit une priorité à associer à un paquet de données. Ledit moteur de commutation reçoit un paquet de données (410). Sur la base des informations contenues dans ce paquet (telles que l'adresse source, l'adresse de destination, la priorité d'étiquette, le port de réception) et d'autres informations (priorités candidates (420), ensemble de drapeaux et table de priorités, par exemple), le moteur de commutation détermine une priorité pour le paquet en question (430).
Patent CA-2396021-A1 (CA)
Inventor: KOSOLOFSKI DAN
IPC: B65D90/24
Filed: 2002-07-26
Abstract: A modular spill containment structure is disclosed comprising two end members, each end member comprising a platform and a peripheral wall on the platform having at least one open side, and mating means for securing the en d members together at their respective open sides. The modular spill containme nt structure further comprises where desired at least one centre member comprising a platform, a peripheral wall on the platform having at least two open sides, and mating means for securing the end members and the at least one centre member togeth er at their respective open sides. The modular spill containment structure is adaptable to provide any desired capacity while being of strong, easily transportable construction. There are no easily damaged or ruptured parts, such as a plastic sheet. Ther e is no need for a deck grating, and the platform accordingly provides a strong, stable support for the containers. In addition, the unique construction of mating members at an open end enables barrier-free communication of leaked liquid to all parts  of the structure to limit the risk of overflow.
Patent CA-2397173-A1 (CA)
Inventor: LIND CLIFTON
IPC: G07F17/32
Filed: 2001-01-04
Abstract: A gaming method according to the invention utilizes a first level game and a  plurality of second level or daughter games. Each game at a particular level  comprises a separate lottery-type game having a number or plurality of game records. Each game record includes a predetermined result. According to the invention, each first level game result is associated with a single value common to the result in each other first level game record. However, the result associated with each second level game record varies between various predetermined prize values.
Patent CA-2398400-A1 (CA)
Title: Surete electromechanique destinee a des armes, et arme equipee de cette surete
Inventor: ALBANESI LUCIANO
IPC: F41A17/06
Filed: 2001-02-13
Abstract: L'invention concerne une sûreté électromécanique destinée à des armes (1), équipée d'un dispositif de sûreté, qui comprend une unité électronique de base, activant un transducteur électromécanique (2) qui agit sur le dispositif mécanique de sûreté, et au moins un émetteur-répondeur, ou transpondeur (5), l'unité de base fournissant une commande centrale et une unité de traitement, reliée à une unité émettrice-réceptrice (4), qui transmet en continu un signal de recherche capable de communiquer avec le(s) transpondeur(s) (5), lorsque ce(s) dernier(s) se situe(nt) dans la portée d'émission de l'unité émettrice-réceptrice (4), le(s) transpondeur(s) n'étant pas alimenté(s) en courant et recevant l'énergie nécessaire à son/leur fonctionnement du signal émis par l'unité émettrice-réceptrice (4), ce(s) transpondeur(s) émette(nt), lorsqu'il(s) est/sont alimenté(s), un code d'identification, l'unité de base actionnant le transducteur électromagnétique (2) de manière à déverrouiller le dispositif mécanique de sûreté lorsque ce dernier reçoit une code d'identification correspondant à un code stocké dans l'unité de base et de manière à le verrouiller dès que l'unité de base de reçoit plus ledit code. L'invention concerne également une arme (1) équipée de cette sûreté électromécanique.
Patent CA-2400434-A1 (CA)
Title: Nouveaux composes
Inventor: PETTERSSON LARS
IPC: A61P3/14
Filed: 2001-02-23
Abstract: L'invention concerne des composés de la formule générale (I) dans laquelle Q, R, R?2¿, R?4¿, R?5¿, R?6¿, R?7¿ et R?8¿ ont la notation définie dans la description, des procédés pour leur préparation, des compositions pharmaceutiques les contenant ainsi que leur utilisation en thérapie.
Patent CA-2401605-A1 (CA)
Inventor: GLATH RAYMOND M
IPC: C10G9/16
Filed: 2001-07-05
Abstract: This invention is a method to inhibit the polymerization of carbonyl compounds in a basic wash unit operation in a hydrocarbon cracking process, wherein a compound selected from the group consisting of alpha-amino acids and esters thereof and amides thereof and salts thereof and mixtures thereof or Mercaptoacetic acid and alkyl esters thereof, is added either to a stream comprising a carbonyl compound or to the basic wash unit operation; wherein the compound is selected such that it remains water-soluble and base-soluble and does not flocculate in the stream or in the basic wash unit operation; and wherein the stream is contacted with the compound either before or at the same time as the stream enters the basic wash unit operation; or wherein the compound is added to the basic wash unit operation before or while the stream enters the basic wash unit operation.
Patent CA-2401919-A1 (CA)
Inventor: HOFFMAN JOSEPH A
IPC: G02B6/00
Filed: 2000-07-25
Abstract: An illumination device including a light guide (22) surrounded by a protective sleeve (24). The light guide (22) is hollow and includes a cylindrical wall (26) having a structured outer surface (28) and a smooth inner surface (30).  Light release structures are provided to reflect or refract light through the cylindrical wall (26) of the light guide (22). In certain embodiments, the protective sleeve is bonded to the light guide. Rigid fixtures can be used to retain the light guide in elastically deformed, non-cylindrical cross-sectional shapes.
Patent CA-2402489-A1 (CA)
Inventor: WILKES DAVID S
IPC: A61K38/095
Filed: 2001-03-15
Abstract: The present invention relates to the use of collagen and MHC-like compounds to down regulate immune responses. Methods for administration of such compounds  that induce immune tolerance are described. The invention is important in th e context of allograft rejection, transplantation, graft rejection, pleural disease and immunotolerance.
Patent CA-2406320-A1 (CA)
Inventor: SYKES CHRISTOPHER C
IPC: A47B21/02
Filed: 2002-10-02
Abstract: Provided is a desk assembly comprising a base adapted to stably engage a floor surface. An upright support member is secured to and extends upwardly from the base. A planar desk is connected in slidable engagement to the support member between a lower and an upper position. Biasing means, preferably a gas spring, is connected between the base and the desk. The biasing means biases the desk upwardly from said lower position toward said upper position. Locking means is operable to selectively secure said desk intermediate said lower and upper positions. The provision of the upwardly biased force, preferably a gas spring, between the upper and lower positions, improves convenience for the user when adjusting height of the desk.
Patent CA-2406815-A1 (CA)
Title: Tarpaulin tensioning arrangement
Inventor: CRAMARO MICHAEL
IPC: B60J7/06
Filed: 2002-10-08
Abstract: A tarpaulin tensioning arrangement includes a lever or leg mounted at one end to a framework extension. A crank having a threaded end is threadably engaged to the lever.  The framework is moved to a tightened condition by rotating the crank until the lever or leg is engaged with a catch to hold one end of the lever or leg in a fixed position.  Continued rotation of the crank causes the framework extension to move in a tensioning direction.
Patent CA-2408617-A1 (CA)
Title: Methods and compositions of matter concerning april/g70, bcma, blys/agp-3, and taci
Inventor: THEILL LARS EYDE
IPC: A61P35/00
Filed: 2001-05-14
Abstract: This invention concerns interactions among APRIL/G70,AGP-3/BLYS, BCMA, and TACI and related methods of use and compositions of matter. It has been foun d that (1) sAPRIL/G70 binds to the cell-surface receptors BCMA and TACI on T a nd B lymphoma cells, resulting in stimulation of proliferation of primary human  and mouse B and T cells both in vitro and in vivo; (2) APRIL competes with AGP3's binding to TACI and BCMA; (3) sBCMA inhibits APRIL and AGP3 binding t o its receptors; (4) sBCMA ameliorates T cell dependent and T cell independent  humoral immune responses in vivo; (5) sTACI inhibits APRIL and AGP3 binding to its receptors and ameliorates T cell dependent and T cell independent humora l immune responses in vivo; and (6) BCMA exhibits similarity with TACI within a single cysteine rich domain located N-terminal to a potential transmembrane domain. These discoverie provides a strategy for development of therapeutics  for treatment of autoimmune diseases, and cancer, for prevention of transpla nt rejection. Disease states and disease parameters associated with APRIL and A GP- 3 may be affected by modulation of BCMA or TACI; disease states and paramete rs associated with TACI can be affected by modulation of APRIL; disease states and parameters can be affected by modulation of any of TACI, BCMA, APRIL and  AGP-3 by a single therapeutic agent or two or more therapeutic agents togeth er.
Patent CA-2410632-A1 (CA)
Title: Nitrosated and nitrosylated taxanes, compositions and methods of use
Inventor: LIN CHIA-EN
IPC: A61F2/82
Filed: 2001-06-22
Abstract: The present invention describes novel nitrosated and/or nitrosylated taxanes, and novel compositions comprising at least one nitrosated and/or nitrosylated taxane, and, optionally, at least one compound that donates, transfers or releases nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor, stimulates endogenous synthesis of nitric oxide or is a substrate for nitric oxide synthase and/or at least one therapeutic agent. The present invention also provides novel compositions comprising at least one taxane and at least one compound that donates, transfers or releases nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor, stimulates endogenous synthesis of nitric oxide or is a substrate for nitric oxide synthase and/or at least one therapeutic agent. The compounds and compositions of the present invention can also be bound to a matrix. The present invention also provides methods for treating or preventing cardiovascular diseases and disorders, autoimmune diseases, pathological conditions resulting from abnormal cell proliferation, polycystic kidney disease, inflammatory disease, preserving organs and/or tissues or to inhibit wound contraction, particularly the prophylactic and/or therapeutic treatment of restenosis, by administering nitrosated and/or nitrosylated taxane or parent taxanes in combination with nitric oxide donors that are capable of releasing nitric oxide or indirectly delivering or transferring nitric oxide to targeted sites under physiological conditions.
Patent CA-2410856-A1 (CA)
Title: Seat recliner and floor latch with interlock
Inventor: HELLRUNG JACOB PAUL
IPC: B60N2/235
Filed: 2001-06-01
Abstract: A latch system (12) for providing adjustment of a seat back (8) relative to a seat bottom (6) includes a seat-back mechanism (16) interconnecting the seat back (8) and the seat bottom (6) for movement of the seat back (8) between a use position and a folded position and a floor-latch mechanism (18) selectively connecting the seat bottom (6) to the base (4) for movement of the seat bottom (6) between a deployed position and a stowed position. An interlock mechanism (14) interacts with the floor-latch mechanism (18) and the seat-back latch mechanism (16) to selectively block operation of the floor-latch mechanism (18) and the seat-back latch mechanism (16).